EurekAlert!3d
KRISS partners with domestic university hospitals to develop disease diagnosis and treatment technology, alleviating patient burden
The Korea Research Institute of Standards and Science (KRISS) announced that they have developed an advanced disease ...
News Medical on MSN16h
Researchers discover how mutations disrupt protein splicing and cause disease
Splicing accuracy enhanced This process is crucial for the life of the cell. "The spliceosome is composed of multiple components that secure production of functional proteins controlling cellular life ...
GlobalData on MSN5d
AlloVir and Kalaris enter merger to advance retinal disease therapies
AlloVir has entered into a definitive agreement for the acquisition of the complete outstanding shares of Kalaris ...
HealthDay on MSN7d
Genetic Testing Rate Lower for Blacks With Inherited Retinal Diseases
The genetic testing rate is lower for Black than non-Hispanic White patients with inherited retinal diseases (IRDs), ...
ophthalmologytimes1d
European Commission grants marketing authorization to aflibercept biosimilar from Sandoz Group
Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.
News Medical on MSN12d
Noninvasive choroidal vessel analysis via deep learning: A new approach to choroidal optical coherence tomography angiography
Researchers from Peking University have introduced a novel deep learning-based method for noninvasive choroidal vessel ...
New Atlas7d
RNA therapy an effective alternative to lifelong, painful eye injections
An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...
The Financial Express1d
European Commission grants approval to Sandoz’s biosimilar to treat retinal diseases
Afqlir is indicated to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD) ...
Taiwan News1d
Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio
Sandoz remains committed to accelerating patient access by strengthening its biosimilar portfolio, reinforcing global and European leadership ...
Medical Xpress8d
Genetic testing rate lower for Blacks with inherited retinal diseases
The genetic testing rate is lower for Black than non-Hispanic White patients with inherited retinal diseases (IRDs), according to a study published online Nov. 7 in JAMA Ophthalmology. Rebhi O.